OFFICIAL PUBLICATION OF

by its subsidiary APPco

Apotex decision a warning bell

Megan Haggan 14/04/2016

Apotex’ decision to pull two of its PBS-listed products should ring an alarm for the health and pharmaceuticals sector, says Belinda Wood, CEO of the Generic and Biosimilar Medicines Association. Yesterday Apotex announced that it will be ceasing supply of two PBS listed prescription products from its portfolio: paracetamol/codeine tablets 500mg/30mg blister pack 20; and

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Wesfarmers targets affordable healthcare

When healthcare is treated as a commodity and patients regarded as consumers, health outcomes are compromised and overall healthcare spending…

Edward Hatfield

‘I can feel the walls closing in on me as this snowballs’

I agree Christine. HMRs and RMMRs are really the success story of advanced practice in Australia. They are supported by…

Debbie Rigby

Wesfarmers targets affordable healthcare

I think the headline should have been "Wesfarmers targets another product line"

Steve Hambleton

Apotex decision a warning bell

Previous Queensland pharmacist vaccination now permanent

Next Aussies encouraged to vaccinate and help kids in India

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Queensland pharmacist vaccination now permanent

Next Aussies encouraged to vaccinate and help kids in India

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.